Looking for Caucasian Clinical Trial Participants in July

Location: 


There's a clinical trial for Caucasian in Inje University Busan Paik Hospital in July, 2016. This drug is already in the market after completing clinical trials. The objective of this trial is extending target to European countries. Please see the details below. If you have any enquiries, please contact [email protected]

<Daewoong study detail>

STUDY DRUG: somatropin, growth hormone (subcutaneous injection, already on the market in Korea and many other countries)

SUBJECTS: Healthy 18 Male subjects (8 per each group)

STUDY SCHEDULE & EXAMINATION

<Hospitalization>

Twice for 4 days and 3 nights: July 8-11 and July 15-18

(Hospitalization at 5~6pm and leaving hospital at 8~9am)

<OPD visit: 4 times>

Screening visit: please see the schedule below

OPD visits (Morning of each hospitalization day): July 8 and 15(around 7~8am)

Post study visit (final visit): choose one day from July 21, 22, 25 and 26 (around 7~8am)

<Examinations>
Physical examination, vital sign/blood pressure, blood/urine test and ECG


COMPENSATION: The compensation will be paid in full after the normal completion of the clinical trial.

Study compensation: KRW 2,200,000 (before tax)

Visit compensation: KRW 150,000(before tax) per each visit (screening, hospitalization, follow-up)

Standby compensation: KRW 150,000 for standby subject (before tax)

  • Tax Information

People with Alien Registration Card: 4.4% tax --> 2,103,200KW after tax

People without Alien Registration Card: 22% tax --> 1,716,000 after tax


INCLUSION/EXCLUSION CRITERIA:

<Inclusion criteria>

* age 20 and 40 years

* BMI range: ≥18.5 and 27kg/m2 

* Caucasian with both parents Caucasian

**Can speak English or Spanish or Russian due to limited study document**

 

<Exclusion criteria>

* Chronic or relevant acute infection

* Intake of drug with a long half life within 21days/ half life within 7days 

* Blood donation of more than 100ml within 30days prior to study drug medication

* Partipation in other clinical trials within 3 months

 

Observed AE from previous trials: headache, localized myalgia, weakness, mild hyperglycemia

Those are the full range of side effects observed in previous trials, none of which are dangerous, just potentially uncomfortable (hence the high compensation). They occurred separately, in rare cases, in trials of a drug which is now in widespread use. Please don't misunderstand or misrepresent the degree of potential harm to subjects involved, this is how progress is made in medical science and it's done with the utmost care and maximal safety precautions.

Choose screening date:

A) 2016-06-18(SAT) 9am

B) 2016-06-20(Mon) 9am OR 1:30pm

C) 2016-06-21(TUE) 9am OR 1:30pm

D) 2016-06-22(WED) 9am OR 1:30pm

E) 2016-06-23(THU) 9am or 1:30pm

F) 2016-06-24(Fri) 9am or 1:30pm